Program Execution Detail
Linked Studies
10
Critical Path Items
4
Escalations
45
Linked Studies
Critical Path Items
Escalations
Program Detail
Program execution detail with dependencies, risks, and linked studies. This workspace exists to enforce consistent clinical execution with accountable ownership, governed evidence, and inspection-ready traceability across the study lifecycle. It supports business and regulatory requirements by connecting operations, quality, submissions, and financial controls in a single system where handoffs are explicit and auditable. Users can proceed by filtering scope, reviewing linked artifacts and actions, and routing escalations with defined approval gates and signature meaning.
Studies In This Program
| Study | Indication | Sites |
|---|---|---|
| STUDY-0004 | KCL-103 | NSCLC | 36 |
| STUDY-0014 | KCL-113 | Hemophilia | 36 |
| STUDY-0024 | KCL-123 | Atopic Dermatitis | 36 |
Program Study Roster
Program Summary | PRG-004Program 4 | Phase I | portfolio PORT-01
STUDY-0004 | KCL-103NSCLC | phase I | milestone drift 0d
STUDY-0014 | KCL-113Hemophilia | phase II | milestone drift 1d
STUDY-0024 | KCL-123Atopic Dermatitis | phase I | milestone drift 2d
Add Program Study Roster Entry
Access & Governance Controls
RBAC+ABACStudy Firewall Active
Operational Controls
Study firewalling chips highlight boundary, country constraints, and vendor partition rules.
Actions requiring GxP control include a human review checkpoint and e-signature meaning capture.
Every state change writes immutable audit evidence with actor, timestamp, and object reference.
Next Actions
Filter to portfolio/program/study context.
Open linked tasks, risks, and document evidence.
Escalate blocked items through governed workflow.